Learn more at HyposMatter.com

Visit HyposMatter.com


Hypoglycemia Is the Major Limiting Factor in Glycemic Control1

Achieving glycemic control without hypoglycemia is a balancing act. Intensive therapy often increases the risk of hypoglycemia1,2

HyposMatter.com provides users with an overview of hypoglycemia as a barrier to glucose control, the direct economic impact of hypoglycemia, and consequences associated with hypoglycemia


to visit HyposMatter.com and learn more!

You May Only Be Seeing the Tip of the Iceberg -
the Consequences of Hypoglycemia Present a Considerable Clinical and Economic Burden

Hypoglycemia is a barrier to glucose control1,3

Severe hypoglycemic events are costly to manage4,5

The consequences associated with hypoglycemia lie beneath the surface6


to learn more about hypoglycemia and how it impacts glucose control, costs, and consequences

A1C=glycated hemoglobin.
References: 1. American Diabetes Association. Standards of medical care in diabetes - 2018. Diabetes Care. 2018;41(suppl 1):S1-S159. 2. DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med. 1991;90(4):450-459. 3. Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health. 2011;14(5):665-671. 4. Heller SR, Frier BM, Hersløv ML, Gundgaard J, Gough SC. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. Diabet Med. 2016;33(4):471-477. 5. Ward A, Alvarez P, Vo L, Martin S. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012). J Med Econ. 2014;17(3):176-183. 6. Frier BM. The economic costs of hypoglycaemia. Br J Diabetes Vasc Dis. 2011;11(suppl 1):S10-S12.

To ensure receipt of future emails, please add novonordisk@email.novonordiskmail.com to your address book.

Please do not respond to this email. If you would like to contact us, please click here or call 1-800-727-6500.

To unsubscribe from future communications from Novo Nordisk Inc., please click here. Additionally, you can unsubscribe from future Novo Nordisk communications by calling 1-877-744-2579 or sending a brief note with your name and address to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536.

Novo Nordisk logo

Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2018 Novo Nordisk All rights reserved. US18DI00011 May 2018

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.